Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced that the US Food and Drug Administration (FDA) has given 510(k) marketing clearance to the PRO-LINK Ti Stand-Alone Cervical Spacer System.
“PRO-LINK Ti offers a low-profile, stand-alone cervical interbody with our groundbreaking Osseo-Loc™ technology. Osseo-Loc is a proprietary surface treatment for titanium with 500-600 microns of porosity, which helps create an environment for potential bone growth,” said Rich Mueller, Chief Operating Officer for Life Spine.
“Due to the structural integrity of titanium, we were also able to include lateral graft windows for maximum bone graft volume and visibility.”
PRO-LINK® Ti is scheduled for full product release by the end of 2016 and joins Life Spine’s portfolio of twenty products launching in 2016.
Life Spine is dedicated to improving the quality of life for spinal patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms.
Life Spine, which is privately held, is based in Huntley, Illinois.